Industrial fermentation using bacteria, yeast and other microbes to produce specific products has the potential to reduce ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more. By Reed Abelson and ...

The emergence of CRISPR-Cas9 genome-editing tools created new opportunities for enhancing plant and crop traits in agricultural biotechnology research. Now, multiplex genome-editing (MGE) technologies ...

the biotechs would combine ViaCyte’s stem cell expertise with CRISPR’s gene editing technologies to develop a potential beta-cell replacement product that could help patients produce their own insulin ...

This CRISPR and Cas9 technology is a groundbreaking ... This essentially could be a cure for insulin-requiring Type I and Type II diabetes. VCTX210 is the base product, with VCTX211 being a ...

Subsequently, DNA repair pathways like non-homologous end joining (NHEJ) or homology-directed repair bring the Cas9 and sgRNA together to ultimately modify the genome. The incorporation of CRISPR ...

“iXCells offers engineered cell products and related services for drug discovery and development using CRISPR-Cas9 technology under a global license agreement. As an innovator in human cell ...

Whilst genome editing with CRISPR-Cas9 is effective, it runs the risk of off-target effects and excessive mutations, which can lead to toxicity. To reduce the likelihood of these occurring, ...

On average, a bacterial genome contains around 30 biosynthetic gene clusters, potentially encoding 30 different natural products. 4 CRISPR/Cas9 gene engineering is expanding the range of these ...

A comprehensive study headed by researchers at Sanford Burnham Prebys has shown that gene editing—specifically gene knockout (KO)—using CRISPR-Cas9 technology can favor cells with mutated ...